Company News: Page (1) of 1 - 01/12/18

Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer


January 12, 2018 -- !-- AddToAny BEGIN -->
This article is no longer available,but here are some related topics.

Page: 1
Related Keywords: Inc.,Medicine,medical technologists,Cancer,Surgery,Medication,Womens Health,Science,Lifestyle,Medical,Biology,Stem Cell,Cancer,Business,Science,

Source:PR Newswire. All Rights Reserved

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved